IP Verse

Knig Szynka Tilmann Von Renesse patent opposition analysis

The comprehensive analysis of Knig Szynka Tilmann Von Renesse opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Knig Szynka Tilmann Von Renesse

Stay updated with the latest patent oppositions filed by Knig Szynka Tilmann Von Renesse

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3747464
 - Mar 26, 2025HEXAL
EP4108782
Compositions And Methods For Analyte DetectionPRESIDENT AND FELLOWS OF HARVARD COLLEGEMar 7, 2024KNIG SZYNKA TILMANN VON RENESSE
EP3265122
Combination Of A Pd-1 Antagonist And Eribulin For Treating CancerEISAI R&D MANAGEMENTJan 23, 2023KNIG SZYNKA TILMANN VON RENESSE
EP3827845
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their UsesJANSSEN BIOTECHDec 27, 2022KNIG SZYNKA TILMANN VON RENESSE
EP3763820
Retroviral Transduction Using PoloxamersREVVITY GENE DELIVERYSep 22, 2022KNIG SZYNKA TILMANN VON RENESSE
EP3521422
Substantially Animal Protein-Free Recombinat Furin And Methods For Producing SameBAXALTA INCORPORATEDJul 6, 2022KNIG SZYNKA TILMANN VON RENESSE
EP2820138
Retroviral Transduction Using PoloxamersREVVITY GENE DELIVERYJul 27, 2021KNIG SZYNKA TILMANN VON RENESSE
EP2382228
Compositions And Methods Of Treating Inflammatory And Autoimmune DiseasesAMGENMay 26, 2021KNIG SZYNKA TILMANN VON RENESSE
EP3570884
Subcutaneous Her2 Antibody FormulationsF HOFFMANN LA ROCHEApr 22, 2021KNIG SZYNKA TILMANN VON RENESSE
EP2691112
Stable Formulations Of Antibodies To Human Programmed Death Receptor Pd-1 And Related TreatmentsMERCK SHARP & DOHMEFeb 25, 2019KNIG SZYNKA TILMANN VON RENESSE

Top clients of Knig Szynka Tilmann Von Renesse

Top companies who are the clients of Knig Szynka Tilmann Von Renesse

CompanyTotal
KNIG SZYNKA TILMANN VON RENESSE9
HEXAL1